IBM Research - Australia

Using Machine Learning to Develop Blood Test For Key Alzheimer’s Biomarker

Alzheimer’s disease, a terminal neurodegenerative disease, has historically been diagnosed based on observing significant memory loss.

Continue reading

AI and the Eye: Deep Learning for Glaucoma Detection

Glaucoma is the second leading cause of blindness in the world, impacting approximately 2.7 million people in the U.S alone [1]. It is a complex set of diseases and, if left untreated, can lead to blindness. It’s a particularly large issue in Australia, where only 50% of all people who have it are actually diagnosed […]

Continue reading

Painting a Clearer Picture of the Heart with Machine Learning

Coronary Artery Disease (CAD) is a condition in which plaque forms on the walls of coronary arteries, causing them to narrow. Eventually, this could lead to a heart attack, or death. This condition is now the single largest health problem in the world, with over one million people in the US undergoing cardiac catheterization – […]

Continue reading